Clinical Trials Browser

Phase 2 × Interventional × rociletinib × Clear all

NCT02147990 2020-08-12

NSCLC

Phase 2 Terminated

318 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT02705339 2016-05-17

Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung